Skip to main content
Caplight Logo









Telescope Therapeutics

Telescope Therapeutics

Private
MontrealHealthcare & Life Scienceshttps://www.telescopetherapeutics.com/

Last Round

Accelerator

Nov 14, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Telescope Therapeutics is a biotechnology company that develops a drug discovery platform using human iPSC-derived disease models and biosensor-based phenotypic evaluation to identify treatments for fibrotic diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

iPSCinduced pluripotent stem celldrug discoverydisease-in-a-dishphenotypic screeningfibrotic diseasebiosensorpreclinical researchself-driving labSDLbiotech platformcontract researchlab automationprecision pharmacology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Telescope Therapeutics Comparables

Compare Telescope Therapeutics with similar companies based on industry and business-model similarity.

Telescope Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Curi Bio
79%
HeartBeat.bio AG
78%
Vivodyne
78%

Telescope Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorNov 14, 2025

Key People

Founding team and executive leadership

Myriam Lavoie

Chief Executive Officer

Executive Team

Telescope Therapeutics Investors

Notable investors and investment history

Telescope Therapeutics investors
InvestorRounds
LvlUp VenturesAccelerator
McGill Dobson Centre for EntrepreneurshipAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 14, 2025

    Secured funding from LvlUp Ventures and McGill Dobson Centre for Entrepreneurship.

  • Jul 17, 2025

    Grew 75% QoQ, from 4 to 7 employees.

Telescope Therapeutics Filings

Explore SEC and related filing metadata, where available.

Telescope Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Telescope Therapeutics's valuation, stock price, and market status.

Is Telescope Therapeutics a public or private company?

Telescope Therapeutics is a private company.

What is the current stock price of Telescope Therapeutics?

Telescope Therapeutics is a private company with no public stock price. Caplight tracks Telescope Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Telescope Therapeutics worth (valuation)?

Valuation information for Telescope Therapeutics is not publicly available.

Can I buy Telescope Therapeutics stock?

Telescope Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Telescope Therapeutics's last funding round?

Telescope Therapeutics's most recent funding round was Accelerator on November 14, 2025.

Who are the main investors in Telescope Therapeutics?

Key investors in Telescope Therapeutics include LvlUp Ventures, McGill Dobson Centre for Entrepreneurship.

Will Telescope Therapeutics IPO soon?

No public IPO plans have been announced for Telescope Therapeutics.

How can I track Telescope Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Telescope Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMontreal
Employee Range3
Year FoundedN/A
Last FundingNov 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?